We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App





Coronavirus More Likely to Infect People with Blood Type A, Finds Study

By HospiMedica International staff writers
Posted on 23 Mar 2020
A new preliminary study in China has found that people having blood type A could be more vulnerable to the coronavirus, while those having type O blood might be more resistant. More...
According to researchers from the Centre for Evidence-Based and Translational Medicine at Zhongnan Hospital of Wuhan University (Wuhan, China) who studied COVID-19 in its outbreak epicenter, Wuhan, and the city of Shenzhen, the proportion of Type-A patients both infected and killed by the coronavirus was found to be “significantly” higher than those with the same blood type among the general public. On the other hand, Type O patients comprised a smaller proportion of those who were infected as well as killed by the coronavirus.

In their study, the researchers compared the blood types of 2,173 confirmed coronavirus patients in Wuhan and Shenzhen with over 3,694 healthy residents in the Wuhan area. According to the published research, 31.16% of the residents in Wuhan had Type-A blood, as against 37.75% of the surveyed coronavirus patients at the Wuhan Jinyintan Hospital having the same blood type. Out of these surveyed coronavirus patients, 25.8% had Type-O blood, as compared to 33.84% of the general population, while 25.8% had Type-O blood, as against 33.84% of the general population. An examination of 206 patients who had died from the coronavirus revealed that 85 victims, or 41.26%, had Type-A blood, while only 52 victims, or about a quarter, had Type-O blood.

“People of blood group A might need particularly strengthened personal protection to reduce the chance of infection,” according to the researchers, who however termed the study as preliminary and stated that more work was needed to confirm the findings.

Related Links:
Centre for Evidence-Based and Translational Medicine at Zhongnan Hospital of Wuhan University


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
New
Warming Cabinet
EC1850BL
New
Pocket Fetal Doppler
CONTEC10C/CL
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The principle of needle-free injection based on the reflection of shock waves through microbubble dynamics (Photo courtesy of Yibo Ma/Kyushu University)

Novel Needle-Free Reagent Injection Method to Reduce Spread of Infectious Diseases

Currently, drug administration for disease treatment and prevention commonly uses injectors with metal needles. However, as the needle directly contacts the patient’s mucus and blood, the use of different... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.